A Study of the Concurrent Use of AGN-190584 and AGN-199201 in Participants With Presbyopia

Summary

This study will identify the optimum concentrations of AGN-199201 and AGN-190584 when dosed in combination once a day for the improvement of uncorrected near visual acuity in participants with presbyopia (inability to focus on items close-up).

Timeline

Start

2016-04-29

Primary completion

2017-10-18

Completion

2017-10-18

Outcome

Met primary endpoint

registry analysis (superiority test); AGN-190584 Vehicle vs AGN-190584 Lower Dose vs AGN-190584 Medium Dose vs AGN-190584 Higher Dose; p <0.0001; Least Squares (LS) 6.6961; Mixed model for repeated measures NCT02595528 ↗

Drugs

Indications